Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CYT005-AllQbG10 for House Dust Mite Allergy
NCT00574223Phase 2Completed
- Sponsor
- Cytos Biotechnology AG
- Start
- Nov 2007
- Primary completion
- Mar 2009
- Modality
- Antisense DNA, Nanoparticles, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of CYT003-QbG10 in perennial allergic rhinoconjunctivitis, sponsored by Cytos Biotechnology AG. Started Nov 2007; status: completed.
02
Drugs
CYT003-QbG10
03
Conditions
perennial allergic rhinoconjunctivitis
Beyond the preview
Go deeper on NCT00574223.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00574223.